New drug candidate STF 1623 activates innate immunity in solid tumors

https://www.news-medical.net/news/20250905/New-drug-candidate-STF-1623-activates-innate-immunity-in-solid-tumors.aspx Cancer immunotherapy, which primes the body's immune system to fight off tumors, has historically focused on harnessing T cells' natural ability to recognize and attack cancer cells.